Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00592657 · ClinicalTrials.gov registry record
Incidence of Rhabdomyolysis Among Patients Admitted With Jimsonweed Ingestions
A clinical trial, sponsored by Akron Children's Hospital.
- Completed
- Registry status
- 46
- Enrollment target
NCT00592657: Completed study, sponsored by Akron Children's Hospital.
NCT00592657 is a clinical trial that has completed, run by Akron Children's Hospital. The registered enrollment target is 46 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00592657 has completed, sponsored by Akron Children's Hospital.
- COMPLETED
- Registry status
- 46 participants
- Enrollment target
Study Summary
Retrospective chart review to determine the presence of rhabdomyolysis among patients admitted to CHMCA from 1997-2007 with Jimsonweed ingestions and to define possible risk factors predisposing patients to the developement of Jimsonweed-associated rhabdomyolysis.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 46 participants |
| Start Date | 2008-01 |
| Est. Completion | 2008-04 |
What the finished NCT00592657 record still lists
NCT00592657 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 46 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT00592657 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00592657 about?
NCT00592657 is a clinical study titled "Incidence of Rhabdomyolysis Among Patients Admitted With Jimsonweed Ingestions". Retrospective chart review to determine the presence of rhabdomyolysis among patients admitted to CHMCA from 1997-2007 with Jimsonweed ingestions and to define possible risk factors predisposing patients to the developement of Jimsonweed-associated rhabdomyolysis.
What is the current status of trial NCT00592657?
This trial is currently completed. The enrollment target is 46 participants. The study started on 2008-01. Estimated completion is 2008-04.
Who is sponsoring clinical trial NCT00592657?
This trial is sponsored by Akron Children's Hospital, which has 27 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01890590 · 46 participants · NA
A Phase II Study of Cyberknife Radiosurgery for Renal Cell Carcinoma
- NCT03191149 · 46 participants · Phase 2
Testing Osimertinib as a Treatment for Lung Cancers With an EGFR Exon 20 Change
- NCT03510208 · 46 participants · Phase 1
Panitumumab-IRDye800 in Diagnosing Participants With Malignant Glioma Undergoing Surgery
- NCT04048278 · 46 participants · Early Phase 1
Lidocaine Infusion in Pancreatic Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia